The earnings call presented a strong performance with record revenue growth and strategic expansions. However, challenges remain in regulatory environments and pricing strategies in certain markets.

Company Guidance

During the third quarter of 2025, Niagen Biosciences reported a record performance with $34 million in revenue, reflecting a 33% increase year-over-year. The company achieved a net income of $4.6 million, up from $1.9 million in the previous year, and ended the quarter with $64.3 million in cash and no debt. The e-commerce segment generated $19 million in net sales, marking a 29% increase, while the distribution business saw a substantial 109% growth, contributing $7 million. The Niagen ingredient business remained stable with $6.9 million in revenue. Additionally, Niagen Biosciences onboarded a new strategic partner with access to over 8,000 medical and healthcare practitioners, intending to boost awareness and distribution of their products. The company also launched Niagen Plus at-home injection kits, available by prescription, and expanded its presence to over 1,000 wellness and healthcare clinics across the United States. The firm revised its full-year revenue growth guidance to 25-30% and highlighted significant opportunities in the NAD market, including potential applications in skincare, cosmetics, food, beverage, and pharmaceuticals.

Record Revenue Growth

Niagen Biosciences reported $34 million in revenue for Q3 2025, a 33% increase year-over-year. Net income was $4.6 million, significantly up from $1.9 million in the previous year.

Strong E-commerce and Distribution Performance

E-commerce net sales reached $19 million, a 29% increase year-over-year. The distribution business grew by 109%, bringing in $7 million in revenue.

New Strategic Partnership

Niagen onboarded a new strategic partner with access to over 8,000 medical and healthcare practitioners, boosting Tru Niagen distributor revenues.

Expansion in NAD Market

The NAD market is expanding rapidly, with opportunities in skincare, cosmetics, food, beverage, and drugs. Niagen is positioning itself as the most effective NAD booster.

Improved Gross Margin and Financial Strength

Gross margin improved to 64.5%, up 100 basis points from last year. The company ended the quarter with $64.3 million in cash and no debt.

Niagen Bioscience (NAGE) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

NAGE Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Mar 11, 2026	2025 (Q4)	0.02 / -	0.09	―	―	―
Nov 04, 2025	2025 (Q3)	0.02 / 0.05	0.029	72.41% (+0.02)
Aug 06, 2025	2025 (Q2)	<0.01 / 0.04	0	―
May 07, 2025	2025 (Q1)	0.02 / 0.06	-0.01	700.00% (+0.07)
Mar 04, 2025	2024 (Q4)	0.02 / 0.09	0	―
Oct 31, 2024	2024 (Q3)	<0.01 / 0.03	0.005	480.00% (+0.02)
Aug 07, 2024	2024 (Q2)	-0.02 / 0.00	-0.03	―
May 08, 2024	2024 (Q1)	-0.02 / -0.01	-0.03	66.67% (+0.02)
Mar 06, 2024	2023 (Q4)	-0.03 / 0.00	-0.02	―
Nov 08, 2023	2023 (Q3)	-0.03 / <0.01	-0.01	150.00% (+0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

NAGE Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 04, 2025	$6.95	$6.88	-1.01%
Aug 06, 2025	$9.40	$9.61	+2.23%
May 07, 2025	$8.45	$9.24	+9.35%
Mar 04, 2025	$5.60	$8.55	+52.68%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Niagen Bioscience (NAGE) report earnings?

Niagen Bioscience (NAGE) is schdueled to report earning on Mar 11, 2026, After Close (Confirmed).

What is Niagen Bioscience (NAGE) earnings time?

Niagen Bioscience (NAGE) earnings time is at Mar 11, 2026, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is NAGE EPS forecast?

NAGE EPS forecast for the fiscal quarter 2025 (Q4) is 0.02.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing